Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

No-Deal Brexit 'Very Bad' For Business And Patients

Executive Summary

Peter Martin, COO of Norgine, is concerned about the ‘mood music’ in the political environment in the UK, and warns about the risks of the UK leaving the EU without a deal in place.

You may also be interested in...



‘Impossible' To Prepare UK Supply Chain For October No-Deal Brexit

The UK parliament's Exiting the EU Committee has heard strong words from industry representatives who say that the sector will not be ready for a no-deal Brexit in in October and that such a scenario would result in stockpiling problems, drug shortages and safety issues.  

UK Pharma Sector ‘Not Ready’ For No-Deal Brexit

A leaked government note has thrown doubt on the ability of the pharma sector to be ready for a no-deal Brexit in October, even though some of the contenders to be the next prime minister say there is nothing to fear from the UK leaving the EU without a deal.

Disorderly Brexit May Necessitate Drug Airlifts, Sanofi UK Head Warns

A badly planned British departure from the EU could make airlifting of drugs into the UK necessary to ensure adequate supplies are maintained, Sanofi’s managing director in the UK said.

Topics

Related Companies

UsernamePublicRestriction

Register

MT142464

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel